Chief Medical Officer,
Cognizant
2023–present · Healthcare & Life Sciences
Founder & CEO,
Innovatim, Inc.
2001–2025 · healthcare strategy & technology consulting · Ohio-registered
Ohio Secretary of State
CMO (enterprise) & portfolio CEO/CMO,
Aspire Universal
2018–2023 · engaged via Innovatim
International advisory
NUHS Singapore · Israel Ministry of Health · N. Macedonia · EU · South America
Managing Director & Executive Consultant,
UPMC
2017–2021 · ~600 staff · HealthPlaNET, $120M
Appointment, ORCID
President & CEO,
The KEW Group
2014–2015 · molecular diagnostics / NGS oncology
EVP & Chief Medical Officer,
Alere Health
2009–2013 · ~2,400 staff · 17M lives under care management
Consultant Staff, General & Trauma Surgery,
Cleveland Clinic
2010–2023 · Digestive Disease & Surgery Institute
Corporate Director, Integrated Cancer Programs,
William Beaumont Hospital
2006–2009 · Program Director, Breast Surgical Oncology Fellowship
Associate Professor of Surgery,
UMDNJ / Rutgers
2004–2006 · Cancer Institute of New Jersey (NCI-designated)
Assistant Professor,
University of Florida
1998–2004 · Surgery; Molecular Genetics & Microbiology · Malcolm Randall VA
Surgical Residency & Fellowship,
Johns Hopkins
1991–1998 · Chief Resident 1996–97 · President, House Staff Council
Endocrine Surgery Fellowship,
University of Oxford / John Radcliffe
1995 · Nuffield Department of Surgery
Co-authored work (Schell, Toogood, Dudley)
MD; PhD, Molecular Immunology; AB, Biology,
University of Chicago
MD 1991 · PhD 1989 (Committee on Immunology) · AB 1984 (honors, Sigma Xi)
MBA,
University of Michigan, Ross School of Business
2009 · with distinction · Beta Gamma Sigma
Founder & Board Chair,
Cohelian
Ohio 501(c)(3) · EIN 42-3656828 · reducing loneliness & social isolation
IRS Tax-Exempt Org Search
Board Member,
Huron Foundation
2020–present · grantmaking for East Cleveland health & well-being
Huron Foundation
Peer-reviewed research
33 publications · h-index 22 · ~1,987 citations · US Patent 9,707,324 B2
Full record, ORCID